D2B3
Biotechnology Research
New Haven, Connecticut, United States
6 employees
- Employees
- 6
D2B3 Overview
- Headquarters
- New Haven, Connecticut, United States
- Website
- d2b3.bio
- Industry
- Biotechnology Research
- Employees
- 6
- Funding
- 500.0K
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About D2B3
D2B3 is a pre-clinical biotechnology company dedicated to advancing drug delivery solutions to the brain and central nervous system. Its proprietary technology allows to transiently and specifically open the blood brain barrier for therapeutic targeting of CNS diseases with high efficacy. Our approach is plug-and-play and works with most drugs and therapeutic classes.
Compare Similar Companies to D2B3
Arvinas
Biotechnology Research
MassBio
Biotechnology Research
Halda Therapeutics
Biotechnology Research
Bexorg, Inc.
Biotechnology Research
Modulate Bio
Biotechnology Research
Lybra Bio
Biotechnology Research
Rho Bio
Biotechnology Research
Stradefy Biosciences
Biotechnology Research
Ensight-AI
Hospitals And Health Care
RedPoint Oncology, Inc
Biotechnology Research